For Bradford mum-to-be Anisa, taking part in a pioneering national health study is about giving babies the best possible start in life.
She is among more than 1,500 women in Bradford who have joined the Generation Study, a major research programme exploring whether rare genetic conditions can be identified in newborn babies early enough for treatment to make a difference.
The study offers participating families genetic screening for more than 200 rare conditions for which treatment is available through the NHS.
For Anisa, the opportunity to contribute to research that could improve children’s health was an important reason to get involved.
“It feels really important to take part in the Generation Study as it’s helping to find out more about how detecting conditions early can make sure babies get the help they need sooner,” she said.
Her participation is part of a growing effort across Bradford to ensure families from different communities have the opportunity to contribute to research that could shape the future of newborn screening.
Giving Bradford families a voice in medical research
Bradford’s diverse population has made accessibility an important part of the local recruitment effort.
Research midwives have been working directly with expectant mothers and their families, explaining how the study works, answering questions and helping parents make informed decisions about participation.
The team regularly visits antenatal clinics, ultrasound departments and maternity inpatient areas, as well as attending community events and local family groups, including toddler groups.
To help overcome language barriers, information about the study is available in several languages, while interpreters are accessible through the maternity service for women whose first language is not English.
The approach is helping ensure that families across Bradford’s communities have the opportunity to understand the research and decide whether they wish to take part.
For women such as Anisa, the study offers an opportunity to contribute to research that could benefit not only their own children but also future generations.
Why early diagnosis matters
Rare genetic conditions can be difficult to identify in newborn babies, particularly when symptoms are not immediately apparent.
In some cases, families face years of uncertainty before receiving a diagnosis, potentially delaying access to treatment and specialist support.
The Generation Study is investigating whether genomic sequencing, which examines a baby’s genetic information, can help identify certain serious conditions at an earlier stage.
The programme screens for more than 200 rare genetic conditions selected because NHS treatment or interventions are available.
Researchers hope that earlier identification could enable affected babies to receive appropriate care sooner, potentially preventing serious complications and improving their long-term health.
Professor Rich Scott, Chief Executive Officer of Genomics England, said the research could transform how serious illnesses are identified and treated.
“We believe genomics can transform healthcare in this country and be used to get ahead of serious illness. It’s been incredibly moving to see the lifechanging impact the Generation Study is having for families,” he said.
“Every year thousands of babies are born in the UK with rare genetic conditions, but they can be hard to diagnose. On average, it takes around five years for a rare condition to be diagnosed, at which point it has often progressed to the point where treatment, if it exists, is far less effective.”
Bradford reaches major milestone
The recruitment of more than 1,500 women represents a significant achievement for Bradford’s research midwives and maternity teams, who have worked to make the programme accessible to local families.
Jenny Butler, Research Midwife and Principal Investigator for the Generation Study in Bradford, praised both the healthcare professionals and the families who have supported the research.
“Enabling more than 1,500 women to take part in this study is a fantastic achievement for Bradford and the team,” she said.
“It demonstrates the commitment of both our team and the families who have chosen to take part.”
She said the research could help improve access to early diagnosis and treatment for babies born with certain genetic conditions.
“By participating in the Generation Study, families from Bradford can access genetic testing through the programme, helping babies receive treatment more quickly if a genetic condition is identified.”
The achievement also reflects the importance of building trust and ensuring medical research is accessible to people from a wide range of backgrounds.
Helping shape the future of newborn healthcare
The Generation Study is part of a national effort to understand whether genomic sequencing could become a useful addition to newborn screening.
As well as potentially helping participating families, the findings could inform future NHS approaches to diagnosing and treating rare genetic conditions.
For Bradford, the milestone demonstrates how local families and maternity professionals are contributing to research with potential benefits far beyond the district.
And for Anisa, being part of the study is a chance to support something that could make a meaningful difference to children’s lives.
Her message is a simple one: identifying health conditions earlier could help babies receive the care they need sooner.
Who can take part?
The Generation Study is open to eligible pregnant women aged 16 or over who are expecting a single baby.
Families interested in participating can speak to their maternity team to find out more about the study, what taking part involves and whether they are eligible.
